The Value of Radiotherapy for Advanced Non-Small Cell Lung Cancer With Oncogene Driver-Mutation.

Front Oncol · 2022 · PMC9139486 · PMID 35646640

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

( 81 ) reported that the PFS and OS were not significantly different between the combination group and TKI group (monotherapy group) (PFS: 13.5 vs 10 months, P=0.175; OS: 33 vs 21 months, P=0.250) in lung adenocarcinoma patients with bone oligometasteses, despite an increasing trend in the local consolidative therapy (LCT) and TKI group (combination group).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.